Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chorioallantoic Membrane | 2 | 2024 | 12 | 0.940 |
Why?
|
| Chickens | 1 | 2022 | 269 | 0.700 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2026 | 481 | 0.550 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 70 | 0.540 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 5 | 0.470 |
Why?
|
| Biomarkers, Tumor | 3 | 2025 | 1585 | 0.470 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 294 | 0.460 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 731 | 0.440 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 679 | 0.440 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 448 | 0.440 |
Why?
|
| Epithelial Cells | 2 | 2015 | 907 | 0.400 |
Why?
|
| Cell Proliferation | 3 | 2026 | 2464 | 0.320 |
Why?
|
| Fatty Acids | 2 | 2026 | 373 | 0.320 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2599 | 0.310 |
Why?
|
| Chick Embryo | 3 | 2026 | 122 | 0.290 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2026 | 15 | 0.240 |
Why?
|
| Receptors, Transferrin | 1 | 2025 | 12 | 0.240 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2025 | 33 | 0.230 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2025 | 33 | 0.230 |
Why?
|
| Smoke | 1 | 2026 | 79 | 0.230 |
Why?
|
| Signal Transduction | 3 | 2025 | 4671 | 0.220 |
Why?
|
| Cigarette Smoking | 1 | 2026 | 91 | 0.220 |
Why?
|
| Heterografts | 2 | 2022 | 191 | 0.210 |
Why?
|
| Neoplasm Invasiveness | 3 | 2025 | 626 | 0.210 |
Why?
|
| Proteogenomics | 1 | 2025 | 111 | 0.200 |
Why?
|
| Antigens, CD | 1 | 2025 | 411 | 0.200 |
Why?
|
| Anoctamin-1 | 1 | 2022 | 3 | 0.180 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2025 | 281 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 4666 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 817 | 0.160 |
Why?
|
| Cisplatin | 1 | 2022 | 273 | 0.160 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 404 | 0.160 |
Why?
|
| Disease Progression | 3 | 2026 | 2193 | 0.150 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 7 | 0.150 |
Why?
|
| Animals | 9 | 2026 | 33846 | 0.150 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 68 | 0.150 |
Why?
|
| Cell Line, Tumor | 5 | 2026 | 3711 | 0.150 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 26 | 0.150 |
Why?
|
| Mice | 7 | 2024 | 18219 | 0.140 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 102 | 0.140 |
Why?
|
| Smoothened Receptor | 2 | 2015 | 31 | 0.140 |
Why?
|
| Urinary Bladder | 1 | 2019 | 219 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2022 | 679 | 0.130 |
Why?
|
| Breast | 1 | 2018 | 214 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 949 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 252 | 0.130 |
Why?
|
| Progesterone | 1 | 2018 | 440 | 0.120 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 631 | 0.120 |
Why?
|
| Estrogens | 1 | 2018 | 429 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2289 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2016 | 147 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2024 | 1000 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 2333 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1121 | 0.100 |
Why?
|
| Endometrium | 1 | 2016 | 292 | 0.100 |
Why?
|
| Biopsy | 1 | 2016 | 1244 | 0.100 |
Why?
|
| Humans | 12 | 2026 | 130374 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1799 | 0.090 |
Why?
|
| Drosophila | 1 | 2015 | 772 | 0.080 |
Why?
|
| Female | 9 | 2025 | 70312 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2011 | 67 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2026 | 756 | 0.070 |
Why?
|
| Risk Factors | 2 | 2018 | 10941 | 0.060 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2025 | 8 | 0.060 |
Why?
|
| Estriol | 1 | 2005 | 12 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2025 | 48 | 0.060 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2005 | 13 | 0.060 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2025 | 82 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 2011 | 0.060 |
Why?
|
| Phenols | 1 | 2005 | 73 | 0.050 |
Why?
|
| Steroids | 1 | 2005 | 169 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2005 | 135 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2025 | 224 | 0.050 |
Why?
|
| Ligands | 1 | 2025 | 482 | 0.050 |
Why?
|
| Estradiol | 1 | 2005 | 461 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1920 | 0.050 |
Why?
|
| DNA Repair | 1 | 2026 | 570 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 526 | 0.050 |
Why?
|
| Histones | 1 | 2026 | 542 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2025 | 1210 | 0.040 |
Why?
|
| Chloride Channels | 1 | 2022 | 56 | 0.040 |
Why?
|
| RNA Editing | 1 | 2001 | 31 | 0.040 |
Why?
|
| Apolipoproteins B | 1 | 2001 | 143 | 0.040 |
Why?
|
| Proteomics | 1 | 2025 | 616 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2001 | 174 | 0.040 |
Why?
|
| Lysosomes | 1 | 2022 | 269 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 43 | 0.040 |
Why?
|
| Zebrafish | 1 | 2022 | 417 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 24 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 55 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 83 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 135 | 0.040 |
Why?
|
| Nucleotides | 1 | 2019 | 88 | 0.040 |
Why?
|
| Swine | 1 | 2022 | 1184 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 382 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 273 | 0.030 |
Why?
|
| Liver | 1 | 2005 | 1788 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 538 | 0.030 |
Why?
|
| Cell Line | 1 | 2022 | 2557 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 324 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3371 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2551 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1712 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1280 | 0.030 |
Why?
|
| Metabolomics | 1 | 2019 | 501 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2011 | 649 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2112 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 20865 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1793 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1113 | 0.020 |
Why?
|
| Middle Aged | 2 | 2025 | 28371 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2011 | 189 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 157 | 0.020 |
Why?
|
| Cell Communication | 1 | 2011 | 189 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 198 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 275 | 0.020 |
Why?
|
| Neoplasms | 1 | 2024 | 2968 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 198 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1362 | 0.020 |
Why?
|
| Macrophages | 1 | 2011 | 660 | 0.020 |
Why?
|
| Male | 2 | 2025 | 64435 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 263 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 1016 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1206 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 995 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2001 | 11 | 0.010 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2001 | 21 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 89 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2001 | 140 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 144 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 4471 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2001 | 173 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 623 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 267 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 363 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 780 | 0.010 |
Why?
|
| Testosterone | 1 | 2005 | 531 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 692 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 2397 | 0.010 |
Why?
|
| Lung | 1 | 2005 | 1533 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 3469 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 31099 | 0.010 |
Why?
|